Anticancer Effects of Ginsenoside Rh2 : A Systematic Review
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
BACKGROUND: As one of the effective pharmacological constituents of Ginseng Radix et Rhizoma, ginsenoside Rh2 (Rh2) exerts a remarkable anticancer effect on various cancer cell lines in vitro and strongly inhibits tumor growth in vivo without severe toxicity.
OBJECTIVE: This article reviewed existing evidence supporting the anticancer effects of Rh2 to classify and conclude previous and current knowledge on the mechanisms and therapeutic effects of Rh2, as well as to promote the clinical application of this natural product.
CONCLUSION: This article reviewed the anticancer efficacies and mechanisms of Rh2, including the induction of cell cycle arrest and programmed cell death, repression of metastasis, alleviation of drug resistance, and regulation of the immune system. Finally, this paper discussed the research and application prospects of Rh2.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Current molecular pharmacology - 15(2022), 1 vom: 01., Seite 179-189 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
He, Xin-Ling [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
78214-33-2 |
|---|
| Anmerkungen: |
Date Completed 31.03.2022 Date Revised 01.04.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2174/1874467214666210309115105 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM322450373 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM322450373 | ||
| 003 | DE-627 | ||
| 005 | 20231225182051.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1874467214666210309115105 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1074.xml |
| 035 | |a (DE-627)NLM322450373 | ||
| 035 | |a (NLM)33687905 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a He, Xin-Ling |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Anticancer Effects of Ginsenoside Rh2 |b A Systematic Review |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.03.2022 | ||
| 500 | |a Date Revised 01.04.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a BACKGROUND: As one of the effective pharmacological constituents of Ginseng Radix et Rhizoma, ginsenoside Rh2 (Rh2) exerts a remarkable anticancer effect on various cancer cell lines in vitro and strongly inhibits tumor growth in vivo without severe toxicity | ||
| 520 | |a OBJECTIVE: This article reviewed existing evidence supporting the anticancer effects of Rh2 to classify and conclude previous and current knowledge on the mechanisms and therapeutic effects of Rh2, as well as to promote the clinical application of this natural product | ||
| 520 | |a CONCLUSION: This article reviewed the anticancer efficacies and mechanisms of Rh2, including the induction of cell cycle arrest and programmed cell death, repression of metastasis, alleviation of drug resistance, and regulation of the immune system. Finally, this paper discussed the research and application prospects of Rh2 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Systematic Review | |
| 650 | 4 | |a Ginseng | |
| 650 | 4 | |a cancer | |
| 650 | 4 | |a cytotoxicity | |
| 650 | 4 | |a ginsenoside Rh2 | |
| 650 | 4 | |a mechanism | |
| 650 | 4 | |a natural compound | |
| 650 | 7 | |a Ginsenosides |2 NLM | |
| 650 | 7 | |a ginsenoside Rh2 |2 NLM | |
| 650 | 7 | |a 78214-33-2 |2 NLM | |
| 700 | 1 | |a Xu, Xiao-Huang |e verfasserin |4 aut | |
| 700 | 1 | |a Shi, Jia-Jie |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Mingqing |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Yitao |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Xiuping |e verfasserin |4 aut | |
| 700 | 1 | |a Lu, Jin-Jian |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current molecular pharmacology |d 2008 |g 15(2022), 1 vom: 01., Seite 179-189 |w (DE-627)NLM185149499 |x 1874-4702 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2022 |g number:1 |g day:01 |g pages:179-189 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1874467214666210309115105 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2022 |e 1 |b 01 |h 179-189 | ||